Prognostic implications of circulating anti-p53 antibodies in lung cancer - A review

European Journal of Cancer Care

Volumn 18, Issue 3, 2009, Pages 248-254

  Kumar, S ^a   Mohan, A ^a   Guleria, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antigen; Diagnosis; Humoral; Protein; Survival; Therapy

Indexed keywords

CANCER ANTIBODY; PROTEIN P53;

BLOOD; HUMAN; IMMUNOLOGY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS;

ANTIBODIES, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65349183487     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2008.01019.x     Document Type: Review

References (40)

1. Bergqvist M., Brattstrom D., Larsson A., Holmertz J., Hesselius P., Rosenberg L., Wagenius G. Brodin O. (1998) p53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy. Anticancer Research 18, 1999 2002. (Pubitemid 28344861)
2. Bergqvist M., Brattstrom D., Lamberg K., Hesselius P., Wernlund J., Larsson A. Wagenius G. (2003) The presence of anti-p53 antibodies in sera prior to thoracic surgery in non-small cell lung cancer patients: its implications on tumor volume, nodal involvement, and survival. Neoplasia 5, 283 287. (Pubitemid 37048605)
3. Bergqvist M., Brattstrom D., Larsson A., Hesselius P., Brodin O. Wagenius G. (2004) The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival. BMC Cancer 4, 66. (Pubitemid 40180288)
4. Béroud C. Soussi T. (1998) p53 gene mutation: software and database. Nucleic Acids Research 26, 200 204. (Pubitemid 28291533)
5. von Brevern M.C., Hollstein M.C., Cawley H.M., De Benedetti V.M., Bennett W.P., Liang L., He A.G., Zhu S.M., Tursz T., Janin N. Trivers G.E. (1996) Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors. Cancer Research 56, 4917 4921. (Pubitemid 26374429)
6. Buccheri G. Ferrigno D. (1994) Prognostic factors in lung cancer: tables and comments. The European Respiratory Journal 7, 1350 1364. (Pubitemid 24235056)
7. Hammel P., Leroy-Viard K., Chaumette M.T., Villaudy J., Falzone M.C., Rouillard D., Hamelin R., Boissier B. Remvikos Y. (1999) Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer. International Journal of Cancer 81, 712 718. (Pubitemid 29214378)
8. Hollstein M., Sidransky D., Vogelstein B. Harris C.C. (1991) p53 mutations in human cancers. Science 253, 49 53.
9. Huncharek M., Kupelnick B., Geschwind J.F. Caubet J.F. (2000) Prognostic significance fo p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies. Cancer Letters 153, 219 226. (Pubitemid 30209865)
10. Jassem E., Bigda J., Dziadziuszko R., Schlichtholz B., Le Roux D., Grodzki T., Rzyman W., Konopa K., Poberezna M., Dobrzanska Z., Skokowski J., Soussi T. Jassem J. (2001) Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance. Lung Cancer 31, 17 23. (Pubitemid 32012599)
11. Kanters S.D., Lammers J.W. Voest E.E. (1995) Molecular and biological factors in the prognosis of non-small cell lung cancer. The European Respiratory Journal 8, 1389 1397.
12. Komiya T., Hirashima T., Takada M., Masuda N., Yasumitsu T., Nakagawa K., Hosono Y., Kikui M., Tsuji S., Fukuoka M. Kawase I. (1997) Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung. Anticancer Research 17, 3721 3724. (Pubitemid 28014928)
13. Labrecque S., Naor N., Thomson D. Matlashewski G. (1993) Analysis of the anti-p53 antibody response in cancer patients. Cancer Research 53, 3468 3471. (Pubitemid 23229621)
14. Lai C.L., Tsai C.M., Tsai T.T., Kuo B.I., Chang K.T., Fu H.T., Perng R.P. Chen J.Y. (1998) Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients. Clinical Cancer Research 4, 3025 3030. (Pubitemid 29001477)
15. Laudanski J., Burzykowski T., Niklinska W., Chyczewski K., Furman M. Niklinski J. (1998) Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer. Lung Cancer 22, 191 200. (Pubitemid 29067393)
16. Laudanski J., Niklinska W., Burzykowski T., Chyczewski L. Niklinski J. (2001) Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer. The European Respiratory Journal 17, 660 666. (Pubitemid 32492554)
17. Lee Y.L., Shih C.M., Chiou H.L., Shiau M.Y., Chang G.C. Chang Y.H. (2004) Alteration of autoantibodies against p53 in Taiwanese lung cancer patients undergoing chemotherapy. Clinica Chimica Acta 349, 87 96. (Pubitemid 39311993)
18. Lubin R., Zalcman G., Bouchet L., Tredanel J., Legros Y., Cazals D., Hirsch A. Soussi T. (1995) Serum p53 antibodies as early markers of lung cancer. Nature Medicine 1, 701 702.
19. Mack U., Ukena D., Montenarh M. Sybrecht G.W. (2000) Serum anti-p53 antibodies in patients with lung cancer. Oncology Reports 7, 669 674.
20. Mitsudomi T., Suzuki S., Yatabe Y., Nishio M., Kuwabara M., Gotoh K., Hatooka S., Shinoda M., Suyama M., Ogawa M., Takahashi T., Ariyoshi Y. Takahashi T. (1998) Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer. Journal of the National Cancer Institute 90, 1563 1568. (Pubitemid 28535722)
21. Mitsudomi T., Hamajima N., Ogawa M. Takahashi T. (2000) Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clinical Cancer Research 6, 4055 4063.
22. Murray P.V., Soussi T., O'Brien M.E., Smith I.E., Brossault S., Norton A., Ashley S. Tavassoli M. (2000) Serum p53 antibodies: predictors of survival in small-cell lung cancer? British Journal of Cancer 83, 1418 1424.
23. Neri M., Betta P., Marroni P., Filiberti R., Cafferata M., Mereu C., Ivaldi G., Montanaro F., Puntoni R. Paganuzzi M. (2003) Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases. Lung Cancer 39, 165 172. (Pubitemid 36173617)
24. O'Byrne K.J., Koukourakis M.I., Giatromanolaki A., Cox G., Turley H., Steward W.P., Gatter K. Harris A.L. (2000) Vascular endothelial growth factor, platelet-derived endothelial cell growth factora nd angiogenesis in non-small cell lung cancer. British Journal of Cancer 82, 1427 1432. (Pubitemid 30175909)
25. Paesmans M., Sculier J.P., Libert P., Bureau G., Dabouis G., Thiriaux J., Michel J., Van Cutsem O., Sergysels R. Mommen P. (1995) Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology 13, 1221 1230.
26. Paesmans M., Sculier J.P., Lecomte J., Thiriaux J., Libert P., Sergysels R., Bureau G., Dabouis G., Van Cutsem O., Mommen P., Ninane V. Klastersky J. (2000) Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 89, 523 533. (Pubitemid 30640099)
27. Parkin D.M., Bray F., Ferlay J. Pisani P. (2005) Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 55, 74 108. (Pubitemid 40372904)
28. Rosenfeld M.R., Malats N., Schramm L., Graus F., Cardenal F., Vinolas N., Rosell R., Tora M., Real F.X., Posner J.B. Dalmau J. (1997) Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer. Journal of the National Cancer Institute 89, 381 385. (Pubitemid 27102603)
29. Sangrajrang S., Sornprom A., Chernrungroj G. Soussi T. (2003) Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking. Lung Cancer 39, 297 301. (Pubitemid 36284730)
30. Schlichtholz B., Legros Y., Gillet D., Gaillard C., Marty M., Lane D., Calvo F. Soussi T. (1992) The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Research 52, 6380 6384.
31. Schlichtholz B., Tredaniel J., Lubin R., Zalcman G., Hirsch A. Soussi T. (1994) Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein. British Journal of Cancer 69, 809 816. (Pubitemid 24140657)
32. Soussi T. (2000) p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Research 60, 1777 1788. (Pubitemid 30207629)
33. Steels E., Paesmans M., Berghmans T., Branle F., Lemaitre F., Mascaux C., Meert A.P., Vallot F., Lafitte J.J. Sculier J.P. (2001) Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. The European Respiratory Journal 18, 705 719. (Pubitemid 33040631)
34. Strauss G.M. (1997) Prognostic markers in resectable non-small cell lung cancer. Hematology/Oncology Clinics of North America 11, 409 434. (Pubitemid 27273138)
35. Trivers G.E., Cawley H.L., DeBenedetti V.M., Hollstein M., Marion M.J., Bennett W.P., Hoover M.L., Prives C.C., Tamburro C.C. Harris C.C. (1995) Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. Journal of the National Cancer Institute 87, 1400 1407.
36. Vennegoor C.J., Nijman H.W., Drijfhout J.W., Vernie L., Verstraeten R.A., von Mensdorff-Pouilly S., Hilgers J., Verheijen R.H., Kast W.M., Melief C.J. Kenemans P. (1997) Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes. Cancer Letters 116, 93 101. (Pubitemid 27226155)
37. Winter S.F., Minna J.D., Johnson B.E., Takahashi T., Gazdar A.F. Carbone D.P. (1992) Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutations. Cancer Research 52, 4168 4174.
38. Winter S.F., Sekido Y., Minna J.D., McIntire D., Johnson B.E., Gazdar A.F. Carbone D.P. (1993) Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer - association with improved survival. Journal of the National Cancer Institute 85, 2012 2018.
39. Zalcman G., Schlichtholz B., Tredaniel J., Urban T., Lubin R., Dubois I., Milleron B., Hirsch A. Soussi T. (1998) Monitoring of p53 auto antibodies in lung cancer during therapy: relationship to response to treatment. Clinical Cancer Research 4, 1359 1366. (Pubitemid 28265217)
40. Zalcman G., Tredaniel J., Schlichtholz B., Urban T., Milleron B., Lubin R., Meignin V., Couderc L.J., Hirsch A. Soussi T. (2000) Prognostic significance of serum p53 antibody in patients with limited-stage small cell lung cancer. International Journal of Cancer 89, 81 86. (Pubitemid 30078754)